|
Re: 002399:CH
|
|
Resverlogix Corp.
|
Jul 11, 2017 04:48PM
|
|
Re: 002399:CH
|
2
|
Resverlogix Corp.
|
Jul 11, 2017 03:23PM
|
|
Re: Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial
|
3
|
Resverlogix Corp.
|
Jul 10, 2017 03:20PM
|
|
Re: Share Price
|
3
|
Resverlogix Corp.
|
Jul 09, 2017 05:45PM
|
|
Share Price
|
1
|
Resverlogix Corp.
|
Jul 09, 2017 03:53PM
|
|
Re: Did you know...?
|
1
|
Resverlogix Corp.
|
Jul 06, 2017 02:37PM
|
|
Re: Reading the tea leaves.....
|
4
|
Resverlogix Corp.
|
Jul 03, 2017 03:45PM
|
|
Value
|
3
|
Resverlogix Corp.
|
Jun 29, 2017 04:29PM
|
|
Re: Removing plaque article
|
1
|
Resverlogix Corp.
|
Jun 27, 2017 02:37PM
|
|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
2
|
Resverlogix Corp.
|
Jun 27, 2017 01:25PM
|
|
Re: Zenith prezzy
|
3
|
Zenith Epigenetics
|
Jun 24, 2017 11:40AM
|
|
Re: Zenith prezzy
|
4
|
Zenith Epigenetics
|
Jun 24, 2017 10:39AM
|
|
Re: Funding
|
1
|
Resverlogix Corp.
|
Jun 23, 2017 02:09PM
|
|
Funding
|
1
|
Resverlogix Corp.
|
Jun 23, 2017 11:56AM
|
|
Re: Managing Diabetes & CVD: Is epigenetics a new way forward?
|
|
Resverlogix Corp.
|
Jun 23, 2017 11:32AM
|
|
Re: Zenith prezzy
|
2
|
Zenith Epigenetics
|
Jun 22, 2017 10:42AM
|
|
Re: Zenith prezzy
|
1
|
Zenith Epigenetics
|
Jun 21, 2017 12:55PM
|
|
Re: Added again....
|
|
Resverlogix Corp.
|
Jun 20, 2017 03:50PM
|
|
Re: Added due to participants
|
3
|
Resverlogix Corp.
|
Jun 20, 2017 12:23PM
|
|
Re: Zacks SCR Report 6/14/17
|
2
|
Resverlogix Corp.
|
Jun 18, 2017 11:58AM
|
